Global Blood Glucose Test Strip Market Research Report - Forecast to 2027

Global Blood Glucose Test Strip Market Research Report - Forecast to 2027

ID: MRFR/MED/0390-CRR | June, 2016 | Region: Global | 110 pages | Cooked Research Reports

Blood Glucose Test Strip Market Information by Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Forecast to 2027


Study Objectives of Blood Glucose Test Strip Market:



  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Global Blood Glucose Test Strip Market

  • To provide insights about factors affecting the market growth

  • To Analyze the Global Blood Glucose Test Strip Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (RoW)

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by Technology, and sub-segments.

  • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Blood Glucose Test Strip Market.



Market Synopsis of Blood Glucose Test Strip Market:


Market Scenario:
Blood glucose test strips are small disposable strips which are used in conjugation with blood glucose meters for monitoring and controlling diabetes. These strips have glucose oxidase impregnated on them, which when reacts with glucose present in the blood gluconic acid. The market for Blood glucose test strips is expected to grow at a CAGR of XX% by the end of the forecasted period.


Segments:
The market for Blood Glucose Test Strip market is segmented on the basis of Technology which includes sub segments like Thick Film Electrochemical, Thin Film Electrochemical and Optical.



Regional Analysis of Blood Glucose Test Strip Market:
North America is a prominent market for Blood Glucose Test Strip market and dominated the Global market share, for Blood Glucose Test Strip market accounting for $XX million and is expected to grow over $XX billion by 2027. The European market is the second largest market for Blood Glucose Test Strip market which is expected to grow at XX% GAGR by the end of the forecasted period.



Key Players for Blood Glucose Test Strip Market:
Some of the key players for this market are: Abbott Laboratories, Acon Laboratories, Inc, Allmedicus, Apex Biotechnology Corporation, Ascensia Diabetes Care Holdings Ag, B.Braun Melsungen Ag, HMD Biomedical, I-Sens, Inc., Lifescan, Inc., Roche Diagnostics, Taidoc Technology Corporation


 
Americas


·   North America


·   US


·   Canada


·   Latin America


Europe


·   Western Europe


·   Germany


·   France


·   Italy


·   Spain


·   U.K


·   Rest of Western Europe


·   Eastern Europe


Asia– Pacific


·   Asia


·   China


·   India


·   Japan


·   South Korea


·   Rest of Asia


·   Pacific


The Middle East & Africa

The report for Global Blood Glucose Test Strip market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

1.1 DEFINITION 9

1.2 SCOPE OF THE STUDY 9

1.2.1 RESEARCH OBJECTIVE 9

1.2.2 ASSUMPTIONS 9

1.2.3 LIMITATIONS 10

1.3 MARKET STRUCTURE 10

2.1 RESEARCH PROCESS 11

2.2 PRIMARY RESEARCH 11

2.3 SECONDARY RESEARCH 11

2.4 MARKET SIZE ESTIMATION 12

2.5 FORECAST MODEL 12

3.1 GROWTH DRIVERS 13

3.1.1 CONVENIENCE OF SELF BLOOD GLUCOSE MONITORING OVER TRADITIONAL METHODS 13

3.1.2 TECHNOLOGICAL ADVANCEMENTS 14

3.1.3 RISING DIABETIC POPULATION 14

3.1.4 PLAYERS ENGAGED IN CREATINGAWARENESS REGARDING REGULAR BLOOD GLUCOSE MONITORING 15

3.1.5 GOVERNMENT INITIATIVES TO PROPEL AUSTRALIAN BLOOD GLUCOSE TEST STRIP MARKET 15

3.1.6 RISING DISPOSABLE INCOME OF EMERGING ECONOMIES 16

3.2 GROWTH BARRIERS 17

3.2.1 INADEQUATE REIMBURSEMENT FOR TEST STRIPS 17

3.2.2 LOW ADOPTION OF SMBG IN EMERGING ECONOMIES AS COMPARED TO DEVELOPED REGIONS 17

3.2.3 ADVENT OF GENERIC BLOOD GLUCOSE TEST STRIPS 17

3.3 OPPORTUNITIES 18

3.3.1 EMERGING ECONOMIES 18

6.1 NORTH AMERICA 24

6.2 EUROPE 28

6.3 ASIA-PACIFIC 31

6.4 LATIN AMERICA 35

6.5 MIDDLE EAST & AFRICA 37

7.1 PRODUCTION CAPACITY 41

7.2 MARKET SHARE ANALYSIS 42

7.2.1 GLOBAL 42

7.2.2 NORTH AMERICA 43

7.2.3 EUROPE 44

7.2.4 ASIA-PACIFIC 44

7.2.5 LATIN AMERICA, MIDDLE EAST, AND AFRICA 45

7.3 COMPARATIVE ANALYSIS 49

7.3.1 COMPARATIVE ANALYSIS: KEY PLAYERS 49

8.1 ABBOTT LABORATORIES 50

8.1.1 BUSINESS OVERVIEW 50

8.1.2 FINANCIALS 51

8.1.3 PRODUCT PORTFOLIO 51

8.1.4 DEVELOPMENTS 51

8.2 ROCHE DIAGNOSTICS 52

8.2.1 BUSINESS OVERVIEW 52

8.2.2 FINANCIALS 52

8.2.3 PRODUCT PORTFOLIO 53

8.2.4 DEVELOPMENTS 53

8.3 LIFESCAN, INC. (A JOHNSON & JOHNSON COMPANY) 54

8.3.1 BUSINESS OVERVIEW 54

8.3.2 FINANCIALS (J&J) 54

8.3.3 PRODUCT PORTFOLIO 55

8.3.4 DEVELOPMENT 55

8.4 I-SENS, INC. 56

8.4.1 BUSINESS OVERVIEW 56

8.4.2 FINANCIALS 56

8.4.3 PRODUCT PORTFOLIO 57

8.4.4 DEVELOPMENT 57

8.5 TRIVIDIA HEALTH (PREVIOUSLY KNOWN AS NIPRO DIAGNOSTICS, INC.) 58

8.5.1 BUSINESS OVERVIEW 58

8.5.2 FINANCIALS 58

8.5.3 PRODUCT PORTFOLIO 59

8.5.4 DEVELOPMENTS 59

8.6 ASCENSIA DIABETES CARE HOLDINGS AG (PREVIOUSLY KNOWN AS BAYER DIABETES CARE) 60

8.6.1 BUSINESS OVERVIEW 60

8.6.2 FINANCIALS 60

8.6.3 PRODUCT PORTFOLIO 61

8.6.4 DEVELOPMENTS 61

8.7 APEX BIOTECHNOLOGY CORPORATION 62

8.7.1 BUSINESS OVERVIEW 62

8.7.2 FINANCIALS 62

8.7.3 PRODUCT PORTFOLIO 63

8.7.4 DEVELOPMENTS 63

8.8 AGAMATRIX INC 64

8.8.1 BUSINESS OVERVIEW 64

8.8.2 FINANCIALS 64

8.8.3 PRODUCT PORTFOLIO 64

8.8.4 DEVELOPMENTS 64

8.9 TAIDOC TECHNOLOGY CORPORATION 65

8.9.1 BUSINESS OVERVIEW 65

8.9.2 FINANCIALS 65

8.9.3 PRODUCT PORTFOLIO 65

8.9.4 DEVELOPMENTS 65

8.10 UNIVERSAL BIOSENSORS 66

8.10.1 BUSINESS OVERVIEW 66

8.10.2 FINANCIALS 66

8.10.3 PRODUCT PORTFOLIO 67

8.10.4 DEVELOPMENTS 67

8.11 BEIJING YICHENG ELECTRONIC CO., LTD. 68

8.11.1 BUSINESS OVERVIEW 68

8.11.2 FINANCIALS 68

8.11.3 PRODUCT PORTFOLIO 68

8.11.4 DEVELOPMENTS 68

8.12 SANNUO BIOSENSOR INC. 69

8.12.1 BUSINESS OVERVIEW 69

8.12.2 FINANCIALS 69

8.12.3 PRODUCT PORTFOLIO 69

8.12.4 DEVELOPMENTS 69

8.13 SHANGHAI MICROSENSE TM INC. 70

8.13.1 BUSINESS OVERVIEW 70

8.13.2 FINANCIALS 70

8.13.3 PRODUCT PORTFOLIO 70

8.13.4 DEVELOPMENTS 70

8.14 ACON LABORATORIES, INC. 71

8.14.1 BUSINESS OVERVIEW 71

8.14.2 FINANCIALS 71

8.14.3 PRODUCT PORTFOLIO 71

8.14.4 DEVELOPMENTS 72

8.15 ALLMEDICUS 73

8.15.1 BUSINESS OVERVIEW 73

8.15.2 FINANCIALS 73

8.15.3 PRODUCT PORTFOLIO 73

8.15.4 DEVELOPMENTS 73

8.16 NATIONAL DIAGNOSTIC PRODUCTS 74

8.16.1 BUSINESS OVERVIEW 74

8.16.2 FINANCIALS 74

8.16.3 PRODUCT PORTFOLIO 74

8.16.4 DEVELOPMENTS 74

8.17 HMD BIOMEDICAL 75

8.17.1 BUSINESS OVERVIEW 75

8.17.2 FINANCIALS 75

8.17.3 PRODUCT PORTFOLIO 75

8.17.4 DEVELOPMENTS 75

8.18 YUWELL-JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. 76

8.18.1 BUSINESS OVERVIEW 76

8.18.2 FINANCIALS 76

8.18.3 PRODUCT PORTFOLIO 76

8.18.4 DEVELOPMENTS 76

8.19 77 ELEKTRONIKA KFT. 77

8.19.1 BUSINESS OVERVIEW 77

8.19.2 FINANCIALS 77

8.19.3 PRODUCT PORTFOLIO 77

8.19.4 DEVELOPMENTS 77

8.20 B. BRAUN MELSUNGEN AG 78

8.20.1 BUSINESS OVERVIEW 78

8.20.2 FINANCIALS 78

8.20.3 PRODUCT PORTFOLIO 79

8.20.4 DEVELOPMENTS 79